Back to announcement
20241126_SILO_Laporan Informasi dan Fakta Material_31791857_lamp2.pdf
Other Text extracted SILOSource file signed link, expires in 15 minutes
Extracted text 3
Page 1
For Immediate Release
PRESS RELEASE
26 November 2024
Strengthening Governance with Visionary Leadership: Siloam Hospitals
Announces New Board of Commissioners and Directors
PT Siloam International Hospitals Tbk (“Siloam” or “Company”; ticker: “SILO”)
Jakarta, 26 November 2024 - PT Siloam International Hospitals Tbk ("SILO" or "the Company"), one of
Indonesia's largest private healthcare providers, announces its new composition of the Board of
Commissioners and Board of Directors upon the resolutions of the Extraordinary General Meeting of
Shareholders conducted on 26 November. The new management appointment is reflecting Siloam’s
commitment to strengthening governance and leadership to drive long-term growth.
Building on a Strong Foundation
The newly appointed members bring diverse and robust expertise across healthcare, finance, law,
investment, and corporate governance. Their collective leadership is poised to navigate emerging challenges
and seize opportunities in Indonesia’s evolving healthcare landscape. The Company also extends its heartfelt
appreciation to the outgoing members for their remarkable contributions, which have been instrumental in
building the foundation of Siloam’s success.
Ensuring Stability for Ongoing Excellence
Recognizing the importance of continuity and stable operations, Siloam has retained key members of the
previous board. Atiff Gill, Daniel Phua, Kartini Sjahrir, and Benny Haryanto Djie continue to play pivotal roles
in guiding the Company’s strategic and financial direction. Daniel Phua, in particular, has been instrumental
in achieving financial excellence, driving sustainable growth, and ensuring the Company’s robust financial
health. These seasoned leaders provide a steady anchor for Siloam as it embarks on this new phase of
innovation and expansion.
Governance: A Strategic Priority
Siloam has consistently upheld excellence in governance as a cornerstone of its operations. Guided by the
outgoing and incoming boards, the Company has streamlined processes, enhanced transparency, and
implemented robust strategies to maintain regulatory compliance and optimize operational efficiency. The
new Board of Commissioners features distinguished global healthcare leaders like Toby Hall, alongside
strategic visionaries such as Sigit Prasetya and Andy Purwohardono, ensuring exceptional oversight and
direction. Furthermore, the appointment of Yasonna H. Laoly as President Commissioner marks a significant
step forward for Siloam Hospitals in strengthening its legal compliance and governance frameworks. With
decades of public service experience and academic expertise, Yasonna’s leadership is set to elevate the
Company’s governance to new heights.
Page 2
Visionary Leadership for Innovation The newly appointed Board of Directors, led by President Director David Utama, signals a renewed focus on driving healthcare innovation. David’s extensive experience in corporate leadership and healthcare technology sets the tone for Siloam’s strategic direction, particularly in expanding patient-centric services and embracing digital transformation. "Siloam Hospitals is entering an exciting era of innovation and impact. Together, we aim to not only meet but exceed the expectations of our patients and stakeholders," said David Utama. Joining the team is Gabriele Isacco Tironi, whose international expertise in operational strategies, portfolio management, and corporate strategy further strengthens Siloam’s commitment to superior patient care. In the meantime, Surya Tatang and Richard Kidarsa are expected to contribute their extensive expertise in investment and corporate finance, further strengthening Siloam’s strategic planning and growth initiatives. Commitment to Sustainability The new leadership reinforces Siloam’s dedication to sustainability, aligning healthcare operations with environmental, social, and governance (ESG) principles. With an emphasis on long-term value creation, the Company will continue to address societal health challenges while minimizing its environmental footprint and upholding rigorous governance standards. As Siloam Hospitals transitions into this new phase of leadership, the Company remains steadfast in its mission to deliver world-class healthcare, backed by a strong commitment to integrity, collaboration, and innovation. The Company expresses its sincere gratitude to the former Board of Directors and Board of Commissioners for their valuable service and contributions to the company’s growth and success during their tenure. We are also pleased to welcome the newly appointed members of the Board of Directors and Board of Commissioners. With their expertise and leadership, we look forward to their contributions in guiding the company towards continued success. For more information, please contact: Investor Relations Siloam Hospitals Group vivian.chandra@siloamhospitals.com Corporate Secretary Siloam Hospitals Group corporate.secretary@siloamhospitals.com
Page 3
About Siloam Hospitals Group PT Siloam International Hospitals Tbk (“Siloam Hospitals”) is a network of private hospitals in Indonesia committed to providing high quality health services in Indonesia. Starting business in 1996, Siloam Hospitals currently manages and operates 41 hospitals, consisting of 15 hospitals in the Greater Jakarta area and 26 hospitals spread across the islands of Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara and Ambon. Siloam Hospitals Group also operates 66 Siloam Clinics. Siloam Hospitals' vision is to provide international quality healthcare and reach all levels of society on a national scale based on Godly compassion which is the basis for Siloam Hospitals to respond to the dynamic social transformation in Indonesia. Siloam Hospitals' mission is to be the trusted choice for world-class holistic healthcare, health education and research. Siloam Hospitals is the pioneer of Joint Commission International (JCI) accreditation for hospitals in Indonesia. JCI is an international accreditation agency based in the United States that focuses on improving the quality of health care and patient safety. For more information about Siloam Hospitals, visit www.siloamhospitals.com. Disclaimer: This Press Release is prepared by Siloam Hospitals and is distributed only to convey general information. This Press Release is not intended for a particular group or purpose and does not constitute a recommendation regarding the shares of Siloam Hospitals. No guarantee is given regarding the completeness or certainty of the information contained. All opinions and estimates included in this Press Release are our opinions as of this date and are subject to change without notice. Siloam Hospitals is not responsible for any losses that may occur to any party due to part or all of the contents of this Press Release, Siloam Hospitals and affiliated companies including their employees and agents are not responsible for any mistakes, omissions, omissions or inaccuracies that can happen. Predictive Statements: Some of the statements in this Press Release are or may be predictive in nature. These statements generally contain words such as "will", "hopes", "anticipates" or the like. By their nature, predictive statements carry risks and uncertainties that may cause realities that are different from what is explained in this Press Release. Factors that can cause different realities include but are not limited to: the economic, social and political situation in Indonesia; the health industry situation in Indonesia; market situation; additional regulatory burdens in Indonesia, including regulations relating to the environment and regulatory compliance costs; fluctuations in foreign exchange rates; interest rate development, capital costs and capital availability; anticipated demand and supply prices related to our health services and related capital expenditures and other investments; construction costs; availability of health services; competition from companies and other locations; changes in customer demand; changes in operational costs, including employee salaries, wages and training, changes in public and government policies; our ability to stay competitive; financial conditions, business strategies and plans and targets set by our management for future work; procurement of future income; compliance with environmental and remediation regulations. If, among other things, one or more of the risks or uncertainties mentioned above occur, the actual results may differ materially than predicted, anticipated or projected. In particular, but not limited, capital costs can increase, projects can be postponed and anticipated increases in production, capacity or implementation may not all occur. Although we believe that our management's expectations expressed in predictive statements are reasonable based on the information we have at the moment, we cannot provide guarantees that these expectations can become reality. You should not depend on these statements immediately. However, these statements apply only to the date they were stated, and we are not responsible for making updates or revisions, even if new information, new events or anything is available.
Names mentioned 10 people and organisations named in the text · linked when the evidence is strong
unresolved
person
H. Laoly
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.